Partnering With Patients in the Development and Lifecycle of Medicines A Call for Action

• Published in: Therapeutic innovation & regulatory science Vol. 49; no. 6; pp. 929 - 939
• Main Authors: Hoos, Anton, Anderson, James, Boutin, Marc, Dewulf, Lode, Geissler, Jan, Johnston, Graeme, Joos, Angelika, Metcalf, Marilyn, Regnante, Jeanne, Sargeant, Ifeanyi, Schneider, Roslyn F., Todaro, Veronica, Tougas, Gervais
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 01.11.2015; Springer International Publishing; Springer Nature B.V
• Subjects: Authorship; Clinical trials; Collaboration; Design; Drug Safety and Pharmacovigilance; Medicine; Partnering; Patients; Pharmaceutical industry; Pharmacotherapy; Pharmacy; Product development; R&D; Research & development; Researchers; Special Populations; Special Populations: Review; medicines development; patient involvement

The purpose of medicines is to improve patients' lives. Stakeholders involved in the development and lifecycle management of medicines agree that more effective patient involvement is needed to ensure that patient needs and priorities are identified and met. Despite the increasing number and sc...